Weight-Based Levothyroxine Dose Calculator for Hypothyroidism in Adults

The Weight-based Levothyroxine Dose Calculator provides a standardized, evidence-based starting dose of levothyroxine. The dosage recommendation is an approximation of the average daily levothyroxine requirement in otherwise healthy adults with primary hypothyroidism. This tool is Intended for use in non-pregnant adults <65 years old without ischemic heart disease who have primary hypothyroidism with minimal endogenous thyroid function (TSH >20 mIU/L and low free T4). This tool is not appropriate for patients with mild or subclinical hypothyroidism (untreated TSH <10–20 mIU/L), as they have residual thyroid function and typically require lower levothyroxine doses. 

Formula

Recommended oral levothyroxine dose (μg/day) = 1.6 × (Weight, kg) 

Best Practices

• Prescribing guidance

  • Levothyroxine tablets are available in standard doses: 25, 50, 75, 88, 100, 112, 125, 137, 150, 175, 200, and 300 mcg.

  • Round the calculated dose by 10–15 mcg to the closest available tablet strength.

  • If a nonstandard dose is desired, clinicians may use pill combinations, tablet splitting, or dosing that varies by day of the week. 

  • Levothyroxine’s long half-life (approximately 7 days) ensures stable thyroid hormone levels despite day-to-day variations; for example, an extra pill 1–2 times per week can be employed to increase a dose.

  • The choice between brand name and generic levothyroxine is guided by availability, cost, and patient preference, as they are equally efficacious.

• Patient instructions

  • Take levothyroxine on an empty stomach with water, ideally first thing in the morning.

  • Wait 30–60 minutes before eating or taking other medications.

  • Separate calcium or iron supplements (including multivitamins) from levothyroxine by at least 4 hours.

  • If evening administration is preferred, take levothyroxine 3–4 hours after the last meal or snack.

  • If a dose is missed, it is generally safe to make up for the missed dose by taking double the levothyroxine the following day.

• Other considerations

  • Requirements that significantly exceed the weight-based dose or >200–300 mcg/day suggest possible malabsorption or medication nonadherence and warrant further evaluation.

  • For ongoing management, monitor TSH and clinical response every 4–8 weeks, adjusting the dose by 12.5–25 mcg as needed. 

  • Consult an endocrinologist for complex or refractory cases, or for further questions or concerns regarding thyroid disease management.

Special populations

• Obesity

  • Using actual body weight may result in overdosing; consider using ideal body weight for patients with increased BMI.

• Older adults and cardiac disease 

  • For patients >65 years or those with ischemic heart disease, doses may be lower to avoid iatrogenic cardiac complications.

  • In the absence of significant hypothyroidism or total thyroidectomy, initiate therapy at lower doses (12.5–25 mcg/day) and titrate gradually.

• Pregnancy

  • Thyroid hormone requirements are generally higher during pregnancy, with starting doses ranging from 1.2–2.3 mcg/kg depending on the severity (mild-to-moderate starting doses are often 50–100 mcg/day). 

  • TSH goals in pregnancy are also tighter to support fetal development: <2.5 mIU/L in the first trimester and <3 mIU/L in the second and third trimesters. 

  • For patients with preexisting hypothyroidism who become pregnant, a 20%–30% dose increase in their pre-pregnancy levothyroxine dose is indicated.

• Thyroid cancer

  • Patients with a history of thyroidectomy for cancer usually require higher levothyroxine doses with lower TSH targets, depending on the stage of thyroid cancer at diagnosis, risk of recurrence, biochemical or structural response to therapy, and patient comorbidities. 

  • Levothyroxine doses in thyroid cancer are typically 2.1–2.7 mcg/kg, with a typical starting dose of approximately 2 mcg/kg/day to achieve appropriate TSH suppression.

• Malabsorption

  • Conditions such as celiac disease, inflammatory bowel disease, gut edema, or concurrent calcium/iron use may reduce levothyroxine absorption and necessitate higher doses. 

  • In severe cases, intravenous or intramuscular therapy may be required.

• Myxedema coma

  • Refer to dedicated guidelines for urgent, high-dose IV levothyroxine treatment.